Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fatima Djouadi

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Nature Genetics|February 12, 2008
Thromboxane synthase mutations in an increased bone density disorder (Ghosal syndrome)David Geneviève, Valérie Proulle, Bertrand Isidor, et al.
Journal of Translational Medicine|April 8, 2024
Wnt, glucocorticoid and cellular prion protein cooperate to drive a mesenchymal phenotype with poor prognosis in colon cancerSophie Mouillet-Richard, Angélique Gougelet, Bruno Passet, et al.
Environment International|May 13, 2025
Triggering tumorigenic signaling: Succinate dehydrogenase inhibitor (SDHi) fungicides induce oncometabolite accumulation and metabolic shift in human colon cellsCarolina Duarte Hospital, Arnaud Tête, Kloé Debizet, et al.
Ebiomedicine|August 5, 2019
The cellular prion protein controls the mesenchymal-like molecular subtype and predicts disease outcome in colorectal cancerDelphine Le Corre, Alexandre Ghazi, Ralyath Balogoun, et al.
Biochimica Et Biophysica Acta|August 10, 2013
Combination of lipid metabolism alterations and their sensitivity to inflammatory cytokines in human lipin-1-deficient myoblastsCaroline Michot, Asmaa Mamoune, Joseph Vamecq, et al.
The Journal of Clinical Investigation|August 8, 2020
Inhibition of mitophagy drives macrophage activation and antibacterial defense during sepsisDanish Patoli, Franck Mignotte, Valérie Deckert, et al.
Gut|May 12, 2021
Human and preclinical studies of the host-gut microbiome co-metabolite hippurate as a marker and mediator of metabolic healthFrançois Brial, Julien Chilloux, Trine Nielsen, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Nature Genetics|February 12, 2008
Thromboxane synthase mutations in an increased bone density disorder (Ghosal syndrome)David Geneviève, Valérie Proulle, Bertrand Isidor, et al.
Journal of Translational Medicine|April 8, 2024
Wnt, glucocorticoid and cellular prion protein cooperate to drive a mesenchymal phenotype with poor prognosis in colon cancerSophie Mouillet-Richard, Angélique Gougelet, Bruno Passet, et al.
Environment International|May 13, 2025
Triggering tumorigenic signaling: Succinate dehydrogenase inhibitor (SDHi) fungicides induce oncometabolite accumulation and metabolic shift in human colon cellsCarolina Duarte Hospital, Arnaud Tête, Kloé Debizet, et al.
Ebiomedicine|August 5, 2019
The cellular prion protein controls the mesenchymal-like molecular subtype and predicts disease outcome in colorectal cancerDelphine Le Corre, Alexandre Ghazi, Ralyath Balogoun, et al.
Biochimica Et Biophysica Acta|August 10, 2013
Combination of lipid metabolism alterations and their sensitivity to inflammatory cytokines in human lipin-1-deficient myoblastsCaroline Michot, Asmaa Mamoune, Joseph Vamecq, et al.
The Journal of Clinical Investigation|August 8, 2020
Inhibition of mitophagy drives macrophage activation and antibacterial defense during sepsisDanish Patoli, Franck Mignotte, Valérie Deckert, et al.
Gut|May 12, 2021
Human and preclinical studies of the host-gut microbiome co-metabolite hippurate as a marker and mediator of metabolic healthFrançois Brial, Julien Chilloux, Trine Nielsen, et al.
Pageof 5